Delivery Order SPE2DR25D1104-SPE2DR26FK554
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,165.74 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens on November 20, 2025, with completion scheduled for November 21, 2025. This delivery order is issued under a firm fixed-price contract structure without any set-aside designation, indicating competitive procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens with a contract ceiling value of $5,984.68. This is a firm fixed-price delivery order with an ultimate completion date of December 4, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, allowing AmerisourceBergen to...
- The Defense Logistics Agency awarded a delivery order valued at $3,007.91 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 2.5 mg/0.5 mL pens on December 8, 2025, with completion scheduled for December 9, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $8,463.35 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections on December 3, 2025, with a completion date of December 4, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply services through AmerisourceBergen's larger contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $15,446.43 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens on November 26, 2025, with an ultimate completion date of November 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement...
- The Defense Logistics Agency has awarded a delivery order valued at $2,669.03 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pens. This competitive award, issued on October 30, 2025, with an ultimate completion date of October 31, 2025, represents a firm fixed price transaction for pharmaceutical delivery to support federal medical supply needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $10,017.00 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 10 mg/0.5 mL pens on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a primary...
- The Defense Logistics Agency awarded a delivery order valued at $31,358.72 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pens on December 8, 2025, with completion targeted for December 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $3,235.08 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 5 mg/0.5 mL pens on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order was placed without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded a $3,962.03 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections on November 14, 2025, with completion targeted for November 17, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's broader...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK554Delivery Order
The Defense Logistics Agency awarded a $1,476.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 5 mg/0.5 mL pens on December 3, 2025, with completion expected by December 4, 2025. This delivery order was issued without a set-aside designation and represents a competitive procurement from AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations. This award is issued under AmerisourceBergen's SPE2DX indefinite delivery/indefinite quantity contract with DLA Troop Support Medical, valued at $999,999,999, which extends through December 2026. The IDC serves as a comprehensive pharmaceutical supply vehicle providing a broad range of medications and medical supplies to support military healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's role as a pharmaceutical prime vendor reflects its status as a major healthcare solutions provider and critical supplier within the federal medical supply chain, demonstrating ongoing capability to meet DLA's pharmaceutical procurement requirements through competitive ordering mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/2/25 |